Total Payments
$2,886
2024 Payments
$320.59
Companies
22
Transactions
126
Medicare Patients
24,666
Medicare Billing
$4.6M
Payment Breakdown by Category
Food & Beverage$2,882 (99.9%)
Travel$4.20 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,882 | 125 | 99.9% |
| Travel and Lodging | $4.20 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $824.15 | 29 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $604.12 | 39 | $0 (2022) |
| Janssen Biotech, Inc. | $351.61 | 13 | $0 (2024) |
| QOL Medical, LLC | $168.50 | 12 | $0 (2022) |
| Lilly USA, LLC | $125.06 | 2 | $0 (2022) |
| Novo Nordisk Inc | $115.87 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $92.68 | 4 | $0 (2019) |
| Alfasigma USA, Inc. | $71.13 | 3 | $0 (2020) |
| Intuitive Surgical, Inc. | $66.93 | 1 | $0 (2020) |
| Quidel Corporation | $63.08 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $320.59 | 5 | ABBVIE INC. ($205.73) |
| 2023 | $417.92 | 8 | Novo Nordisk Inc ($115.87) |
| 2022 | $825.11 | 42 | ABBVIE INC. ($349.02) |
| 2021 | $349.75 | 21 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($244.97) |
| 2020 | $448.51 | 24 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($153.72) |
| 2019 | $57.95 | 3 | Otsuka America Pharmaceutical, Inc. ($24.06) |
| 2018 | $193.50 | 12 | Otsuka America Pharmaceutical, Inc. ($46.24) |
| 2017 | $272.69 | 11 | AbbVie, Inc. ($114.82) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $114.86 | General |
| Category: Immunology | ||||||
| 08/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $160.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: IMMUNOLOGY | ||||||
| 07/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: IMMUNOLOGY | ||||||
| 01/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: IMMUNOLOGY | ||||||
| 12/07/2023 | Myriad Women's Health, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $42.99 | General |
| Category: ONCOLOGY | ||||||
| 09/28/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/21/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/03/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $109.18 | General |
| Category: Immunology | ||||||
| 04/26/2023 | Quidel Corporation | — | Food and Beverage | In-kind items and services | $63.08 | General |
| 03/23/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $115.87 | General |
| Category: Obesity | ||||||
| 01/26/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: IMMUNOLOGY | ||||||
| 01/10/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/21/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Gastroenterology | ||||||
| 12/09/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/01/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: Immunology | ||||||
| 12/01/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: Immunology | ||||||
| 11/30/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Gastroenterology | ||||||
| 11/17/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $110.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2022 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Immunology | ||||||
| 10/27/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $10.28 | General |
| Category: Immunology | ||||||
| 10/13/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $9.43 | General |
| Category: Immunology | ||||||
| 10/07/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: IMMUNOLOGY | ||||||
| 09/29/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 4,936 | 17,414 | $4.5M | $901,686 |
| 2022 | 16 | 6,333 | 19,935 | $5.2M | $1.1M |
| 2021 | 28 | 7,518 | 25,765 | $7.0M | $1.4M |
| 2020 | 12 | 5,879 | 23,050 | $6.3M | $1.3M |
Total Patients
24,666
Total Services
86,164
Medicare Billing
$4.6M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 2,237 | 12,357 | $3.8M | $726,306 | 19.0% |
| 88364 | Genetic sequencing localization, each additional procedure | Office | 2023 | 804 | 2,658 | $252,510 | $72,098 | 28.6% |
| 88365 | Genetic sequencing localization, initial procedure | Office | 2023 | 804 | 886 | $106,320 | $30,316 | 28.5% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2023 | 269 | 284 | $85,200 | $20,801 | 24.4% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 139 | 220 | $59,400 | $18,173 | 30.6% |
| 87506 | Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 6-11 targets | Office | 2023 | 32 | 33 | $21,714 | $8,505 | 39.2% |
| 88360 | Microscopic genetic analysis of tumor, manual | Office | 2023 | 47 | 183 | $37,515 | $6,100 | 16.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 156 | 215 | $27,950 | $5,900 | 21.1% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 52 | 83 | $24,485 | $5,360 | 21.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 60 | 60 | $27,000 | $3,017 | 11.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 37 | 97 | $9,700 | $2,170 | 22.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 112 | 130 | $3,957 | $1,092 | 27.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 81 | 92 | $3,312 | $952.20 | 28.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 85 | 95 | $5,225 | $722.95 | 13.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 21 | 21 | $630.00 | $174.09 | 27.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 2,152 | 12,607 | $3.9M | $745,425 | 19.1% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2022 | 1,425 | 1,757 | $526,960 | $129,461 | 24.6% |
| 88364 | Genetic sequencing localization, each additional procedure | Office | 2022 | 995 | 3,284 | $311,980 | $92,005 | 29.5% |
| 88365 | Genetic sequencing localization, initial procedure | Office | 2022 | 997 | 1,113 | $133,560 | $39,694 | 29.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 139 | 293 | $79,110 | $25,636 | 32.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 133 | 215 | $63,425 | $13,300 | 21.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 134 | 143 | $64,350 | $7,271 | 11.3% |
| 87507 | Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 12-25 targets | Office | 2022 | 14 | 14 | $16,170 | $5,747 | 35.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 145 | 166 | $21,580 | $4,673 | 21.7% |
| 88360 | Microscopic genetic analysis of tumor, manual | Office | 2022 | 35 | 131 | $26,855 | $4,454 | 16.6% |
About Dr. Stephen Oh, D.O
Dr. Stephen Oh, D.O is a Anatomic Pathology & Clinical Pathology healthcare provider based in Murrieta, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2008. The National Provider Identifier (NPI) number assigned to this provider is 1881867695.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Oh, D.O has received a total of $2,886 in payments from pharmaceutical and medical device companies, with $320.59 received in 2024. These payments were reported across 126 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,882).
As a Medicare-enrolled provider, Oh has provided services to 24,666 Medicare beneficiaries, totaling 86,164 services with total Medicare billing of $4.6M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Murrieta, CA
- Active Since 04/12/2008
- Last Updated 11/28/2016
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1881867695
Products in Payments
- XIFAXAN (Drug) $360.56
- RINVOQ (Biological) $298.18
- TRULANCE (Drug) $295.27
- SKYRIZI (Biological) $253.25
- STELARA (Biological) $177.98
- MAVYRET (Drug) $141.18
- MOUNJARO (Drug) $125.06
- Wegovy (Drug) $115.87
- TREMFYA (Drug) $114.86
- Humira (Biological) $114.82
- Sucraid (Drug) $93.32
- BREATHTEK (Device) $92.68
- SUCRAID (Drug) $75.18
- Da Vinci Surgical System (Device) $66.93
- REMICADE (Biological) $58.77
- INJECTAFER (Drug) $55.29
- MYRISK (Device) $42.99
- OCALIVA (Drug) $36.82
- Axonics r-SNM System (Device) $31.78
- Zelnorm (Drug) $26.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.